Temaril-P®

Temaril-P® Tablets

Temaril-P® combines the antipruritic and antitussive action of trimeprazine with the anti-inflammatory action of prednisolone. Temaril-P® is recommended for the relief of itching regardless of cause. Its usefulness has been demonstrated for the relief of itching and the reduction of inflammation commonly associated with most skin disorders of dogs such as the eczema caused by internal disorders, otitis, and dermatitis (allergic, parasitic, pustular, and nonspecific). It often relieves pruritus which does not respond to other therapy. Temaril-P® has been found to be effective therapy and adjunctive therapy in various cough conditions of dogs. Therefore, in addition to its antipruritic action, Temaril-P® is recommended for the treatment of “kennel cough” or tracheobronchitis, bronchitis including all allergic bronchitis and infections and coughs of nonspecific origin.

Dogs

Temaril-P® tablets provide long-lasting relief from itching and coughing. Reduces the inflammation of most canine skin disorders, such as eczema, otitis and dermatitis. Recommended for treatment of various cough conditions, including kennel cough and bronchitis. Provides 3-way therapeutic effect: antipruritic, antitussive, anti-inflammatory.

trimeprazine tartrate, prednisolone

Side effects may include drowsiness, increased thirst, increased appetite, excessive urination, dull, dry hair coat, weight gain, vomiting, diarrhea, stomach upset, depression, reduced activity level, increased aggression. If symptoms persist and appear troublesome, contact your veterinarian.

Other side effects may occur. If you notice anything unusual, contact your veterinarian.

Temaril-P® should be given orally as directed by your veterinarian.

Prolonged treatment with Temaril-P® must be withdrawn gradually. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies, including deformed forelegs, phocomelia, and anasarca.

Quite often your veterinarian may prescribe two different medications, and a drug interaction may be anticipated. In this case, your veterinarian may vary the dose and/or monitor your pet more closely. The following drugs can potentially interact with prednisolone: amphotericin B, potassium depleting diuretics, digitalis glycosides, salicylates, insulin, phenytoin, phenobarbital, rifampin, cyclosporine, cyclophosphamide, mitotane, non-steroidal anti-inflammatory drugs, and anticholinesterase agents. Contact your veterinarian if your pet experiences any unusual reactions when different medications are given together.

Allergic reactions to medications may occur. Be sure to inform VetSource and your veterinarian if your pet has any known drug sensitivities or allergies. If your pet displays symptoms of an allergic reaction, call your veterinarian immediately or go to a veterinary emergency clinic. Symptoms may include but are not limited to: swollen lips, tongue, face, airways; difficulty breathing; agitation; profuse salivation; vomiting; widespread hives and itching.